NMS · Medical - Instruments & Supplies

KMTS (KMTS) Stock

$23.99 +5.08% NMS: KMTS Healthcare

Valuation

MetricValue
Price$23.99
Market Cap$1.41B
P/E Ratio-3.85
P/B Ratio5.62
P/S Ratio13.66
EPS (TTM)$-5.13
52-Week High$30.00
52-Week Low$13.25
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-55.61%
ROA-38.51%
ROCE-51.46%
Gross Margin-176.67%
Operating Margin-176.67%
Net Margin-1.73%
Debt/Equity0.01
Current Ratio6.71

Annual Financials (USD)

Metric20202021202320242025
Revenue$0$0$8.0M$28.0M$60.0M
Operating Profit$-29.0M$-33.0M$-80.0M$-85.0M$-106.0M
Net Profit$-29.0M$-34.0M$-84.0M$-94.0M$-114.0M
EPS$-0.59$-0.69$-1.75$-2.04$-5.13
Op Margin——-1054.0%-305.8%-177.8%

Balance Sheet (USD)

Metric20202021202320242025
Total Assets$8.0M$31.0M$39.0M$46.0M$296.0M
Total Liabilities$4.0M$29.0M$156.0M$255.0M$90.0M
Cash$6.0M$24.0M$15.0M$8.0M$238.0M
Borrowings$0$23.0M$39.0M$45.0M$44.0M

Latest News

Kestra Medical Technologies Ltd (KMTS) Q4 2026 Earnings Call Highlights: Record Revenue Growth ... GuruFocus.com · Jul 15, 2026 Kestra Medical Technologies Q4 Earnings Call Highlights MarketBeat · Jul 14, 2026 Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates Zacks · Jul 14, 2026 Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing GlobeNewswire · Jul 14, 2026 Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results GlobeNewswire · Jul 14, 2026

Cash Flow (USD)

Metric20202021202320242025
Operating Cash Flow$-30.0M$-30.0M$-70.0M$-72.0M$-78.0M
Investing Cash Flow$0$-1.0M$-31.0M$-25.0M$-47.0M
Financing Cash Flow$30.0M$29.0M$0$-2.0M$13.0M
Net Cash Flow$0$19.0M$11.0M$-7.0M$229.0M
Free Cash Flow$-31.0M$-30.0M$-85.0M$-85.0M$-101.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-10.49%
Quick Ratio7.32
Interest Coverage-13.25
Return 1Y29.01%
Return 3Y—
Return 5Y—

Ownership

Insiders Held5.30%
Institutions Held102.47%
Institutions Float Held108.20%
Institutional HolderSharesReport Date
Bain Capital Investors Llc25,172,3382026-03-31
Price (T.Rowe) Associates Inc5,968,6642026-03-31
FMR, LLC5,721,0542026-03-31
Andera Partners2,695,1922026-03-31
Yu Fan2,282,5192026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AZTA $29.88 +6.22% -15.22 $1.38B 0.00%
BLFS $32.15 +2.78% -96.00 $1.57B 0.00%
EVOEvotec SE $2.01 -6.07% -3.26 $713.93M 0.00%
NEOG $9.29 +1.09% -1.69 $2.02B 0.00%
NVCR $16.39 +4.46% -15.27 $1.91B 0.00%

About KMTS

KMTS is led by CEO Brian Webster, employs 300 people, headquartered in US, publicly traded since 2025.

KMTS stock trades at $23.99 with a market capitalization of $1.41B. The stock is valued at a price-to-earnings (P/E) ratio of -3.85, price-to-book of 5.62, price-to-sales of 13.66. Over the past 52 weeks the stock has ranged between $13.25 and $30.00, and currently trades 20.0% below its 52-week high.

On profitability, KMTS generates a return on equity (ROE) of -55.61%, return on capital employed of -51.46%, an operating margin of -176.67%, a net profit margin of -1.73%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides